Our Pricing

Managing Constipation On Wegovy Prescription Weight Loss

Published on: June 03, 2026

Experiencing constipation on wegovy uk prescription treatment is one of the most commonly reported gastrointestinal side effects, affecting approximately 24% of patients in clinical trials [1]. At Cured Pharmacy, our UK-registered clinical team provides evidence-based guidance to help you manage this side effect whilst continuing your weight loss journey safely and effectively.

Why Wegovy Causes Constipation

Wegovy contains semaglutide, a GLP-1 receptor agonist that slows gastric emptying as part of its therapeutic mechanism [1]. This delayed stomach emptying helps you feel fuller for longer, contributing to weight loss, but it also means food moves more slowly through your entire digestive system.

In the STEP clinical trial programme, constipation was reported in 24% of participants taking semaglutide compared to 11% on placebo [1]. The effect is dose-dependent, meaning higher doses may increase the likelihood of experiencing this side effect. Understanding this mechanism helps explain why the symptom often improves as your body adjusts to each new dose level.

GLP-1 medications also affect the muscles in your intestinal wall, reducing their contractions and further slowing transit time [2]. This pharmacological action, whilst beneficial for appetite control, can lead to harder stools and infrequent bowel movements if not managed proactively.

Evidence-Based Strategies for Managing Constipation on Wegovy

Increasing your daily fluid intake to at least 2 litres is the most effective first-line intervention for constipation on wegovy uk prescription treatment [3]. Adequate hydration softens stools and facilitates easier passage through the slower-moving digestive system. Many patients find setting hourly reminders helpful during the initial dose escalation phases.

Dietary fibre should be increased gradually to 25-30 grams daily through whole grains, vegetables, fruits, and legumes [3]. Sudden increases can worsen bloating, so aim to add 5 grams weekly whilst monitoring your response. Soluble fibre from oats, psyllium husk, and ground flaxseed is particularly beneficial as it absorbs water and creates softer, bulkier stools.

Regular physical activity stimulates intestinal contractions and can significantly improve bowel regularity [4]. Even a 20-minute daily walk has been shown to reduce constipation severity in patients taking GLP-1 medications. The combination of movement and adequate hydration often provides relief within 3-5 days of implementation.

When to Consider Over-the-Counter Remedies

If lifestyle modifications haven't provided adequate relief after one week, osmotic laxatives such as macrogol (Movicol) or lactulose may be appropriate [3]. These work by drawing water into the bowel, softening stools without causing dependency. Our superintendent pharmacist Tarun Kumar recommends starting with the lowest effective dose and using them short-term whilst continuing dietary and hydration strategies.

Stimulant laxatives like senna or bisacodyl should be reserved for occasional use only, as regular use can lead to tolerance and worsen bowel function over time [3]. Always consult with a healthcare professional before starting any laxative regimen, particularly if you're taking other medications or have underlying health conditions.

Constipation on Wegovy vs Other Weight Loss Medications

Different weight loss medications affect the digestive system in varying ways. Whilst Wegovy and other GLP-1 receptor agonists commonly cause constipation due to delayed gastric emptying, medications like Orlistat work through fat malabsorption and typically cause the opposite effect—loose, oily stools [2].

Mounjaro, containing tirzepatide, is a dual GIP/GLP-1 receptor agonist that may cause constipation in approximately 20-26% of patients—a similar rate to semaglutide-based treatments [5]. Saxenda, containing liraglutide, is a daily injection that also slows gastric emptying but may produce slightly lower rates of constipation due to its shorter duration of action.

Understanding these differences helps you and your prescriber make informed treatment decisions. If constipation proves particularly troublesome despite management strategies, your UK prescriber may consider adjusting your dose escalation schedule or discussing alternative weight loss approaches during your follow-up consultations.

Dietary Modifications for Constipation Relief

Prunes and prune juice contain sorbitol, a natural laxative compound that can provide gentle relief when consumed regularly [4]. Starting with 50ml of prune juice or 3-4 prunes daily alongside your morning routine often produces results within 24-48 hours without causing cramping or urgency.

Kiwi fruit has demonstrated particular efficacy in clinical studies, with two kiwis daily shown to improve bowel frequency and stool consistency [4]. The fruit contains actinidin, an enzyme that aids protein digestion, and high levels of both soluble and insoluble fibre. This makes it an excellent addition to breakfast or as an evening snack.

Probiotic-rich foods such as live yoghurt, kefir, sauerkraut, and kimchi support healthy gut bacteria populations that influence bowel regularity [4]. Whilst research on probiotics for GLP-1-related constipation is still emerging, maintaining diverse gut microbiota through fermented foods offers broader digestive health benefits with minimal risk.

Foods to Limit During Wegovy Treatment

Processed foods high in refined carbohydrates and low in fibre can worsen constipation by providing bulk without the structural components needed for healthy bowel movements. White bread, pastries, and heavily processed snacks should be minimised in favour of whole-grain alternatives.

Excessive dairy consumption may contribute to constipation in some individuals, particularly if you're reducing overall food volume due to Wegovy's appetite-suppressing effects [3]. If you notice worsening symptoms, try reducing cheese and full-fat dairy for one week whilst ensuring adequate calcium intake from alternative sources like fortified plant milks or leafy greens.

When to Contact Your Prescriber About Constipation

Severe constipation lasting more than one week despite lifestyle modifications requires clinical review [6]. Warning signs include inability to pass gas, severe abdominal pain, vomiting, or blood in stools—these may indicate bowel obstruction and require urgent medical attention.

If constipation is significantly impacting your quality of life or causing you to consider stopping Wegovy treatment, contact your prescriber before making any changes to your medication regimen. They may recommend temporarily pausing dose escalation, adjusting your injection timing, or providing prescription-strength interventions whilst you continue treatment.

Patients with pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS-C), inflammatory bowel disease, or previous bowel surgery should discuss constipation risk factors during their initial consultation [6]. Proactive management strategies can be implemented from your first dose to minimise discomfort and support treatment adherence.

Long-Term Bowel Health on Wegovy Prescription

Most patients find that constipation improves significantly after the first 8-12 weeks of treatment as the body adapts to semaglutide's effects on gastric motility [1]. Maintaining the dietary and hydration strategies that provided initial relief helps prevent recurrence, particularly during dose increases.

Regular monitoring of your bowel patterns allows early intervention if symptoms return. Many patients find keeping a simple diary noting bowel frequency, stool consistency, fluid intake, and fibre consumption helps identify patterns and triggers. This information is valuable during follow-up consultations with your prescriber.

At Cured Pharmacy, Wegovy treatment includes ongoing clinical support from UK-registered prescribers who can adjust your treatment plan based on your individual response and side effect profile. Starting from £79.00, our transparent pricing includes free online consultation, discreet delivery, and access to our clinical team throughout your weight loss journey. All prescription medications require online clinical assessment by a UK prescriber to ensure safe, appropriate treatment tailored to your medical history.

Building Sustainable Habits Beyond Constipation Management

The lifestyle modifications that address constipation—increased water intake, higher fibre consumption, and regular physical activity—are the same evidence-based behaviours that enhance weight loss outcomes and long-term weight maintenance [2]. Viewing constipation management as an opportunity to establish these foundational health habits creates lasting benefits beyond symptom relief.

As you progress through your Wegovy treatment and approach your weight loss goals, these habits become the cornerstone of maintaining your results. The digestive system adaptations you've supported through proactive management contribute to improved metabolic health, better nutrient absorption, and enhanced overall wellbeing that extends well beyond the duration of your prescription treatment.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Nauck, M. A., et al. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
3. Bharucha, A. E., & Lacy, B. E. (2020). Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology, 158(5), 1232–1249. https://doi.org/10.1053/j.gastro.2019.12.034 [accessed 13 August 2026]
4. Dimidi, E., et al. (2019). Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Advances in Nutrition, 8(3), 484–494. https://doi.org/10.3945/an.116.014407 [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. Camilleri, M., et al. (2017). Chronic constipation. Nature Reviews Disease Primers, 3, 17095. https://doi.org/10.1038/nrdp.2017.95 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.